Our findings elucidate the IRP1-SCAP axis as a critical modulator of lipid metabolic reprogramming in aggressive FLSs, underscoring its potential as a therapeutic target for RA by modulating the 'iron-lipid' crosstalk. Here, SCAP is linked to rheumatoid arthritis.